https://www.bakersfield.com/ap/news/datopotamab-deruxtecan-late-breaking-data-at-esmo-breast-shows-promising-preliminary-response-and-disease-control/article_bdb49fb3-dac0-5a1b-9585-841f91987819.html
Datopotamab Deruxtecan Late-Breaking Data at ESMO Breast Shows Promising Preliminary Response and Disease Control in Patients with Metastatic Triple Negative Breast Cancer | News | bakersfield.com